1. Home
  2. BDL vs SER Comparison

BDL vs SER Comparison

Compare BDL & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDL
  • SER
  • Stock Information
  • Founded
  • BDL 1959
  • SER 2017
  • Country
  • BDL United States
  • SER United States
  • Employees
  • BDL N/A
  • SER N/A
  • Industry
  • BDL Restaurants
  • SER Biotechnology: Pharmaceutical Preparations
  • Sector
  • BDL Consumer Discretionary
  • SER Health Care
  • Exchange
  • BDL Nasdaq
  • SER Nasdaq
  • Market Cap
  • BDL 48.0M
  • SER 53.5M
  • IPO Year
  • BDL N/A
  • SER 2018
  • Fundamental
  • Price
  • BDL $23.86
  • SER $5.70
  • Analyst Decision
  • BDL
  • SER Strong Buy
  • Analyst Count
  • BDL 0
  • SER 1
  • Target Price
  • BDL N/A
  • SER $11.00
  • AVG Volume (30 Days)
  • BDL 1.7K
  • SER 14.5K
  • Earning Date
  • BDL 05-13-2025
  • SER 05-24-2025
  • Dividend Yield
  • BDL 2.15%
  • SER N/A
  • EPS Growth
  • BDL N/A
  • SER N/A
  • EPS
  • BDL 1.78
  • SER N/A
  • Revenue
  • BDL $193,230,000.00
  • SER $56,000.00
  • Revenue This Year
  • BDL N/A
  • SER N/A
  • Revenue Next Year
  • BDL N/A
  • SER N/A
  • P/E Ratio
  • BDL $13.07
  • SER N/A
  • Revenue Growth
  • BDL 8.87
  • SER N/A
  • 52 Week Low
  • BDL $23.44
  • SER $3.81
  • 52 Week High
  • BDL $29.72
  • SER $14.57
  • Technical
  • Relative Strength Index (RSI)
  • BDL 38.99
  • SER 59.63
  • Support Level
  • BDL $23.22
  • SER $4.75
  • Resistance Level
  • BDL $24.17
  • SER $5.94
  • Average True Range (ATR)
  • BDL 0.49
  • SER 0.33
  • MACD
  • BDL -0.10
  • SER 0.02
  • Stochastic Oscillator
  • BDL 12.28
  • SER 67.31

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service and Package stores consist of retail liquor sales and related items. The company generates maximum revenue from Restaurant segment.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: